HIV-1 dynamics after transient antiretroviral therapy: Implications for pathogenesis and clinical management
Simple models of CD4 lymphocyte interactions with human immunodeficiency virus (HIV) lead to the hypothesis that progression of HIV infection involves an increase in viral replicative capacity, due either to changes in the virus or in the host environment, or both. In order to consider how changes i...
Saved in:
Published in | Journal of medical virology Vol. 53; no. 3; pp. 261 - 265 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Wiley Subscription Services, Inc., A Wiley Company
01.11.1997
Wiley-Liss |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Simple models of CD4 lymphocyte interactions with human immunodeficiency virus (HIV) lead to the hypothesis that progression of HIV infection involves an increase in viral replicative capacity, due either to changes in the virus or in the host environment, or both. In order to consider how changes in plasma virus load after transient, potent antiretroviral therapy can be used to test the above hypothesis—a simple mathematical model that encompasses the processes of (1) arrival of new CD4 lymphocytes, (2) death/removal of these cells by HIV‐independent mechanisms, (3) infection of susceptible CD4 lymphocytes by HIV, and (4) death/removal of infected cells was investigated. This showed that the in vivo rate of increase in plasma virus load immediately after transient therapy provides a measure of the viral replicative capacity. Thus, the hypothesis that progression of HIV infection involves an increase in viral replicative capacity can be tested by measuring this viral growth rate in patients with high CD4 counts and in patients with low CD4 counts. Studies should thus investigate dynamics of changes in virus levels after stopping antiretroviral therapy and, in particular, measure rates of increase in virus in patients at high and low CD4 counts. In practice, such data may assist in therapeutic management of patients with HIV infection. J. Med. Virol. 53:261–265, 1997. © 1997 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-83GWTZ1D-4 ArticleID:JMV14 Special Trustees of the Royal Free Hospital istex:583512FCCACD819BA63F922BC18B8060712BE08E ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0146-6615 1096-9071 |
DOI: | 10.1002/(SICI)1096-9071(199711)53:3<261::AID-JMV14>3.0.CO;2-K |